Jiang Cao

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

Zhiling Yan, Jiang Cao, Hai Cheng et al. · The Lancet Haematology · 2019 · 317 citations

Life Sciences, Hematology, Immunology +16

Electrophysiological Findings During Ablation of Persistent Atrial Fibrillation With Electroanatomic Mapping and Double Lasso Catheter Technique

Feifan Ouyang, Sabine Ernst, Julian Chun et al. · Circulation · 2005 · 221 citations

Medicine, Cardiology, Surgery +17

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng et al. · American Journal of Hematology · 2018 · 174 citations · Full text

Life Sciences, Immunology, Oncology +17

FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics

Li Li, Yanchao Zhao, Qi Zhang et al. · Scientific Reports · 2019 · 144 citations · Full text

Medicine, Bioinformatics, Oncology +17

Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial

Ming Shi, Jiaojiao Wang, Hongming Huang et al. · Nature Communications · 2024 · 104 citations · Full text

Medicine, Immunology, Oncology +16